OPRX News and Press, OptimizeRx Corporation From 04/03/23

2023-04-03 17:16:43 ET Summary OptimizeRx Corporation is an interesting company with an investment thesis based on its ability to capture a large TAM, with customers being some of the largest pharma companies out there. The company's financial position is robust and they have been...

ROCHESTER, Mich., March 29, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, has been named to the Financial Times (the “FT”) li...

2023-03-17 11:21:08 ET Summary A series of storms have left large swaths of the Western part of the United States with significant snow much to the delight of skiers. One of the largest mountain resort companies in the world is going to benefit from these conditions and it is not ...

2023-03-14 07:46:44 ET OptimizeRx ( NASDAQ: OPRX ) has announced a share repurchase program to buyback up to $15M of its outstanding common stock. The announcement follows the health technology company's fourth quarter results For further details see: Optimiz...

ROCHESTER, Mich., March 14, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, announced today that its Board of Directors has unanimously autho...

2023-03-09 08:10:22 ET Point-of-care technology solutions provider, OptimizeRx ( NASDAQ: OPRX ) announced a multi-million-dollar, three-year agreement with a leading Hub services company. It will leverage OptimizeRx technology to accelerate patient access for its life...

ROCHESTER, Mich., March 09, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today announced a multi-million-dollar, three-year agreement with...

2023-03-08 22:23:03 ET OptimizeRx Corporation (OPRX) Q4 2022 Earnings Conference Call March 08, 2023 04:30 PM ET Company Participants Will Febbo - CEO Ed Stelmakh - CFO and COO Steve Silvestro - Chief Commercial Officer Conference Call Participants Ry...

2023-03-08 17:20:45 ET OptimizeRx ( NASDAQ: OPRX ) is down ~19% in after-hours trading after its Q4 2022 revenue results missed expectations and its 2023 revenue growth guidance came in well below consensus. In 2023, the company said it expects net revenues to increase...

2023-03-08 16:04:23 ET OptimizeRx press release ( NASDAQ: OPRX ): Q4 Non-GAAP EPS of $0.25 beats by $0.01 . Revenue of $19.7M (-3.0% Y/Y) misses by $2.07M . For the full year 2023, the company expects net revenues to increase at least 10% year-over-year. T...